Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

Stroke

Volumn 35, Issue 11, 2004, Pages 2518-2522

  Smith, Wade S ^a,c   Dowd, Christopher F ^a   Johnston, S Claiborne ^a   Ko, Nerissa U ^a   DeArmond, Stephen J ^a   Dillon, William P ^a   Setty, Deepa ^b   Lawton, Michael T ^b   Young, William L ^b   Higashida, Randall T ^a   Halbach, Van V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

Endovascular therapy; Papaverine; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

CHLORBUTOL; PAPAVERINE; PRESERVATIVE; VERAPAMIL;

ADULT; AGED; ANEURYSM; ANTERIOR CEREBRAL ARTERY; ANTERIOR COMMUNICATING ARTERY; BRAIN ARTERY; BRAIN VASOSPASM; CONFERENCE PAPER; DIFFUSION WEIGHTED IMAGING; FEMALE; GLASGOW COMA SCALE; GRAY MATTER; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; NEUROLOGIC EXAMINATION; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; WHITE MATTER;

AGED; BRAIN; CHLOROBUTANOL; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PAPAVERINE; PRESERVATIVES, PHARMACEUTICAL; RETROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 7644242976     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000144682.00822.83     Document Type: Conference Paper

References (21)

1. Weir B, Grace M, Hansen J, Rothberg C. Time course of vasospasm in man. J Neurosurg. 1978;48:173-178.
2. Fisher CM, Roberson GH, Ojemann RG. Cerebral vasospasm with ruptured saccular aneurysm - the clinical manifestations. Neurosurgery. 1977;1:245-248.
3. Polin RS, Coenen VA, Hansen CA, Shin P, Baskaya MK, Nanda A, Kassell NF. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2000;92:284-290.
4. Bejjani GK, Bank WO, Olan WJ, Sekhar LN. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery. 1998;42:979-986; discussion 986-977.
5. Eskridge JM, McAuliffe W, Song JK, Deliganis AV, Newell DW, Lewis DH, Mayberg MR, Winn HR. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery. 1998;42:510-516; discussion 516-517.
6. Katoh H, Shima K, Shimizu A, Takiguchi H, Miyazawa T, Umezawa H, Nawashiro H, Ishihara S, Kaji T, Makita K, Tsuchiya K. Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res. 1999;21:195-203.
7. Firlik KS, Kaufmann AM, Firlik AD, Jungreis CA, Yonas H. Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Surg Neurol. 1999;51:66-74.
8. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 1992;77:842-847.
9. Feng L, Fitzsimmons BF, Young WL, Berman MF, Lin E, Aagaard BD, Duong H, Pile-Spellman J. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol. 2002;23:1284-1290.
10. Andaluz N, Tomsick TA, Tew JM Jr, van Loveren HR, Yeh HS, Zuccarello M. Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: experience at the University of Cincinnati. Surg Neurol. 2002;58:131-138; discussion 138.
11. Morikawa N, Nakagawa-Hattori Y, Mizuno Y. Effect of dopamine, dimethoxyphenylethylamine, papaverine, and related compounds on mitochondrial respiration and complex 1 activily. J Neurochem. 1996;66:1174-1181.
12. Liberman EA, Tsofina LM. Effect of phosphodiesterase inhibitors on the membrane potential and respiration of mitochondria. Biofizika. 1984;29:158-159. In Russian.
13. Urakov AL, Baranov AG. Effect of papaverine on the energy processes of myocardial mitochondria. Farmakol Toksikol. 1979;42:132-136. In Russian.
14. Carhuapoma JR, Qureshi AI, Tamargo RJ, Mathis JM, Hanley DF. Intra-arterial papaverine-induced seizures: case report and review of the literature. Surg Neurol. 2001;56:159-163.
15. Bhattacharjee AK, Kondoh T, Ikeda M, Kohmura E. MMP-9 and EBA immunoreactivity after papaverine mediated opening of the blood-brain barrier. Neuroreport. 2002;13:2217-2221.
16. Yoshimura S, Hashimoto N, Goto Y, Sampei K, Tsukahara T, Iihara K. Intraarterial infusion of high-concentration papaverine damages cerebral arteries in rats. AJNR Am J Neuroradiol. 1996;17:1891-1894.
17. Nordt SP. Chlorobutanol toxicity. Ann Pharmacother. 1996;30:1179-1180.
18. DeChristoforo R, Corden BJ, Hood JC, Narang PK, Magrath IT. High-dose morphine infusion complicated by chlorobutanol-induced somnolence. Ann Intern Med. 1983;98:335-336.
19. Valentour JC, Sunshine I. Chlorobutanol poisoning. Report of a fatal case. Z Rechtsmed. 1975;77:61-63.
20. Malinovsky JM, Lepage JY, Cozian A, Mussini JM, Pinaudt M, Souron R. Is ketamine or its preservative responsible for neurotoxicity in the rabbit? Anesthesiology. 1993;78:109-115.
21. Clouston JE, Numaguchi Y, Zoarski GH, Aldrich EF, Simard JM, Zitnay KM. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol. 1995;16:27-38.